Skip to content

ERAS in Elderly Colorectal Cancer Surgery

Short-Term Outcomes of Minimally Invasive Surgery in Elderly Colorectal Cancer Patients in the Era of ERAS: is a One-Size-Fits-All Strategy Sufficient?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06764888
Acronym
STOMIS-ERAS
Enrollment
1392
Registered
2025-01-09
Start date
2024-06-05
Completion date
2024-12-05
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colo-rectal Cancer, Elderly (people Aged 65 or More), ERAS, Minimally Invasive Surgery

Brief summary

Enhanced recovery protocol consisted of a series of elements aiming to optimize and standardize perioperative care. This study aims to evaluate the safety and feasibility of a modified ERAS protocol following colorectal surgery in the elderly population, aged 65 years or older. This is a retrospective study based on prospectively collected data. Patient privacy has been carefully protected throughout the research process, and no aspect of this study interfered with or altered the patients' treatment or clinical care.

Interventions

None listed

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* they underwent radical resection for colorectal cancer * the procedure was minimally invasive surgery * they were aged 65 or older * they provided signed informed consent.

Exclusion criteria

* Patients who underwent emergency surgery for colorectal cancer. * Patients with incomplete medical records or missing data relevant to the study. * Patients with synchronous malignancies or a history of other cancers within the past five years. * Patients with severe comorbidities (e.g., advanced cardiovascular, respiratory, or renal diseases) that contraindicate ERAS protocol implementation. * Patients with preoperative metastatic disease or locally advanced tumors requiring palliative procedures. * Patients who did not comply with or complete the ERAS protocol during the perioperative period.

Design outcomes

Primary

MeasureTime frameDescription
Short-term postoperative complications rate.3 monthsMeasurement outcomes included the rate of short-term postoperative complications, overall morbidity, early morbidity, reoperation rate, 30-day readmission rates and 30-day mortality rates. Postoperative complications were carefully recorded and classified using the Clavien-Dindo classification system for a standardised severity evaluation. These complications are critical for assessing surgical outcomes and ensuring patient safety. Early complications were defined as those occurring during the initial hospitalisation or within 30 days of surgery, while late complications were defined as those arising after the patient's discharge from the hospital.

Secondary

MeasureTime frameDescription
Days of Hospital Stay and Time to First Passage of Flatus3 monthsMeasurement outcomes are the rate of post-operative recovery times, including postoperative stay(days) and first passage of flatus(days).

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026